Yet again, the markets are under COVID’s spell
The US
The fact that Pfizer has a vaccine which is 95% effective in preventing COVID-19 infections didn’t impress the markets. Investors focused on the new restrictions that could be enforced to curb the number of infections, threatening the economic rebound. USA30 fell 1.16%, while USA500 lost 1.17%. TECH100 closed 0.82% lower.
Crude oil settled up 1% at $41.82 a barrel.
Gold traded at $1,880.15 per ounce.
The Dollar Index inched 0.15% lower at 92.263.
Asia and Australia
The benchmarks ended the trading session mixedly. Some markets were driven by the better-than-expected exports, which could make the chances for a fiscal stimulus from the Bank of Japan slimmer. On the other hand, markets closed higher for the third consecutive day and even reached new highs. The boost came from the gains reported in the automotive sector and Moderna’s potential COVID-19 vaccine.
Japan225 lost 1.10%.
HongKong45 closed 0.49% higher.
Down under, Australia200 finished up 0.51%, reaching a high unseen since March 3.
Europe
The fact that more and more countries are going back into lockdown made investors lose hope in a post-pandemic economic rebound. Germany30 and France40 lost 0.1%. UK100 dropped 0.3%.
Brent oil traded at $44.34 after it gained 1.3%.
EUR/USD went up 0.2% at 1.1879.
EUR/GBP lost 0.33%, trading at 0.8922.
Sources: reuters.com, investing.com
Die Benutzer / Die Leser sollten sich nicht nur auf die hier präsentierten Informationen verlassen und sollten ihre eigene Forschung / Analyse durchführen, indem sie auch die eigentliche zugrunde liegende Forschung lesen.Der Inhalt ist dabei generisch und wird nicht die individuelle persönliche Umstände,Anlageerfahrungen oder die aktuelle finanzielle Situationen berücksichtigten.
Daher übernimmt Key Way Investments Ltd keine Haftung für Verluste von Händlern aufgrund der Verwendung und des Inhalts der hierin enthaltenen Informationen. Die in der Vergangenheit gezeigte Performance und gemachten Prognosen sind kein zuverlässiger Indikator für künftige Ergebnisse.
